Original Research Article
Year: 2022 | Month: November | Volume: 9 | Issue: 11 | Pages: 409-413
DOI: https://doi.org/10.52403/ijrr.20221155
Cervical Cancer: Incidence, Clinical Staging at Presentation and Treatment Modality from October 2020-March 2021
Bridget Omo Usen1, Ademola Biala2, Geremias Rangel3
1Just Completed Medical Internship, Awaiting Residency
2,3Senior Registrar, Obstetrics and Gynecology Department, Georgetown Public Hospital Corporation, Georgetown, Guyana
Corresponding Author: Bridget Omo Usen
ABSTRACT
Objective: The aim of the research is to attempt to ascertain the incidence of cervical cancer at GPHC, most common clinical stage and histologic types at presentation and treatment modalities offered for different stages of the disease at the national referral hospital in Guyana.
Methodology: A retrospective chart review of the registry from the gynecology-oncology clinic of the Georgetown Public Hospital Corporation from October 1st, 2020 to March 31st 2020.
Results: There were a total of 33 new cases of cervical cancer admitted into the registry of the gynecology-oncology clinic of the Georgetown Public Hospital Corporation for the study period. The modal age of presentation was 41-50 years. Women of African and East Indian descent (36.36% each) accounted for the highest pool of disease among the six (6) races in Guyana. The International Federation of obstetrics and Gynecology (FIGO) Stage III disease was the predominant stage at presentation (42.4%). Squamous cell carcinoma (SCC) accounted for 93.94% of histologic diagnoses.
Conclusion: The late presentation (stage III) of 42.4% of patients with a tissue diagnosis of SCC (93.94% of the study cohort) of predominantly of African and East Indian descents and between the modal ages of 41-50 years were the main findings of this study. Preventative and pragmatic programs targeting these demographic subsets will go a long way in reducing the burden of disease in Guyana.
Keywords: Cervical Cancer, Stage; Histology; Treatment
[PDF Full Text]